Reuters logo
4 个月内
BRIEF-Immunovaccine presents preclinical research on novel monoclonal antibodies
2017年4月5日 / 上午11点24分 / 4 个月内

BRIEF-Immunovaccine presents preclinical research on novel monoclonal antibodies

1 分钟阅读

April 5 (Reuters) - Immunovaccine Inc-

* Immunovaccine Inc presents preclinical research at aacr 2017 on ability of novel monoclonal antibodies to boost efficacy of depovax(tm)-based cancer immunotherapy

* Immunovaccine-Data demonstrated phosphatidylserine targeting antibodies can enhance anti-cancer activity of depovax-based therapeutic vaccine platform

* Immunovaccine Inc - data suggests that antibody targeting ps can increase anti-tumor immune response induced by a depovax-based cancer immunotherapy Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below